Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Latest News about Ram Mukunda

Recent news which mentions Ram Mukunda

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
Tickers IGC NEWS
Tags Health Care Alzheimer's cannabinoid/based drug News
From Benzinga
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
Tickers DRUG IGC
Tags Benzinga Top Stories IGC Pharma's breakthrough Alzheimer's drug
From Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
Tickers IGC
Tags IGC Ram Mukunda Earnings
From Benzinga
Cannabis Based Pain Relief Solution Receives European Patent Approval
Tickers IGC
Tags IGC patent pharma
From Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
Tickers POTX TOKE
Tags Biotech Market News Benzinga
From Benzinga
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
Tickers IGC
Tags IGC Markets Cannabis
From Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
Tickers IGC
Tags Benzinga Market News News
From Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
Tickers IGC
Tags Cannabis premium Ram Mukunda
From Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
Tickers IGC
Tags IGC Markets premium
From Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
Tickers IGC
Tags Markets IGC Cannabis
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.